Cagrilintide 5mg+Semaglutide 5mg

This peptide combination stack includes Cagrilintide and Semaglutide, formulated to support weight management, appetite control, and metabolic health. It is primarily studied in research and clinical trial settings for enhanced weight loss and improved glycemic regulation.
Cagrilintide mimics the hormone amylin, promoting satiety, slowing gastric emptying, and reducing calorie intake.
Semaglutide is a GLP-1 receptor agonist that helps regulate blood sugar, reduce appetite, and support weight loss.
The combination is typically administered via subcutaneous injection and provides a synergistic effect for appetite suppression and metabolic support. It is not yet widely approved for general medical use, and professional guidance and supervision are strongly recommended.